newsfilter
← Latest News
Business Wire·

GoodRx Reports Fourth Quarter and Full Year 2024 Results

Fourth Quarter and Full Year 2024 Results Substantially In-line with Previous Guidance GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading